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SummAry – As an n-methyl-d-aspartate antagonist, magnesium sulfate has analgesic pro-
perties and reduces noxious input during surgery. The aim of the study was to determine the effect of 
preemptive intravenous low-dose magnesium sulfate on early postoperative pain after laparoscopic 
cholecystectomy. in this prospective, randomized study, 60 ASA i-ii patients undergoing elective 
laparoscopic cholecystectomy were assigned to three groups (n=20 each). After anesthesia induction, 
prior to surgical incision, patients received magnesium sulfate 5.0 mg/kg (group A), magnesium 
sulfate 7.5 mg/kg (group B) or saline intravenously (group C). general anesthesia was performed 
with the same drugs in all three groups. Postoperative pain intensities at rest, according to the visual 
analog scale (vAS 0-10), were evaluated at 1, 3, 6, 9 and 24 hours after surgery. According to the 
vAS scores, patients intravenously received metamizol 2.5 g (vAS 3-4), diclofenac 75 mg (vAS 5-7) 
or tramadol 1 mg/kg (vAS 8-10). vAS scores at 1 hour postoperatively were significantly lower in 
groups A (4.7±1.7; p<0.05) and B (3.2±1.8; p<0.01) than in group C (5.2±2.0). At 3 hours postopera-
tively, vAS score was significantly lower in group B (2.4±1.5) than in group A (3.7±1.8) or group C 
(3.8± 2.3) (p<0.05). After 6, 9 and 24 hours postoperatively, there were no differences in vAS scores 
among the groups. in conclusion, preemptive intravenous administration of both 5.0 mg/kg and 7.5 
mg/kg of magnesium sulfate significantly reduced early postoperative pain after laparoscopic chole-
cystectomy, but 7.5 mg/kg was found to be more effective. There was no effect on pain reduction at 
6, 9 and 24 hours after surgery and no adverse effects were recorded.
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Introduction
laparoscopic cholecystectomy is the gold standard 
in the treatment of symptomatic cholelithiasis. One 
of the major advantages over open cholecystectomy is 
reduced postoperative pain1,2, although it still remains 
the most prevalent complaint in the early postopera-
tive hours after laparoscopy.
Postoperative pain after laparoscopic cholecystec-
tomy can be divided into three major groups according 
to localization: incisional pain (somatic pain), visceral 
pain (deep intra-abdominal pain) and shoulder pain3. 
incisional pain predominates and is the most intense 
on the day of surgery and the following day4,5. inter-
ventions before the noxious stimulus causing central 
sensitization may attenuate or block sensitization and 
reduce acute pain and analgesic consumption6.
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magnesium, the fourth most common cation in 
human body, is a calcium channel blocker and reg-
ulates calcium influx in the cell7. The n-methyl-d-
aspartate (nmdA) receptor is an ionotropic receptor 
for glutamate and aspartate situated throughout the 
brain and spinal cord and is modulated by a number 
of endogenous and exogenous compounds. nmdA 
receptor blockade prevents induction of central sen-
sitization due to peripheral nociceptive stimulation 
and abolishes hypersensitivity once it is established8,9. 
magnesium is a noncompetitive antagonist of the 
nmdA receptors and its associated ion channels, 
and therefore a very effective drug in the treatment of 
postoperative pain. 
The aim of this prospective randomized study was 
to determine the effect of two preemptive intravenous 
low-doses of magnesium sulfate (7.5 mg/kg and 5.0 
mg/kg) on early postoperative pain (during the first 
three hours after surgery) in patients with symptom-
atic cholelithiasis undergoing laparoscopic cholecys-
tectomy.
Patients and Methods
with the approval of the hospital ethics Com-
mittee and after a written informed consent had been 
obtained, 60 ASA i or ii physical status patients 
of both sexes, aged 18-75 years, with symptom-
atic cholelithiasis scheduled for elective laparoscopic 
cholecystectomy were enrolled and randomly assigned 
to one of the three groups (n=20 each). exclusion cri-
teria were contraindications to any of the drugs used 
in the study, preexisting neurologic or psychiatric ill-
ness, and a history of drug or alcohol abuse. Patients 
were randomized to receive intravenously magnesium 
sulfate before surgical incision in a dose of 5.0 mg/kg 
(group A), magnesium sulfate 7.5 mg/kg (group B) or 
saline (group C).
The anesthetic management of patients was stan-
dardized. All patients were premedicated with oral 
midazolam (7.5 mg) 45 minutes before surgery. An-
esthesia was induced with midazolam 0.2 mg/kg 
and propofol 1.5 mg/kg, followed by vecuronium 0.1 
mg/kg to facilitate tracheal intubation. fentanyl in a 
dose of 3 µg/kg was given before surgical incision and 
nasogastric tube was inserted during the procedure. 
The lungs were mechanically ventilated with oxygen/
n2O, keeping the end-tidal CO2 at 35-40 mm hg. 
Throughout the procedure, intravenous infusion of 
500-1000 ml of ringer solution was administered 
and in case of inadequate muscle relaxation, inter-
mittent bolus of vecuronium 0.04 mg/kg was added. 
during the laparoscopy, intra-abdominal pressure 
was maintained at 12 mm hg. Trocar insertion sites 
were not infiltrated with local anesthetic nor was 
intraperitoneal local anesthetic administered. Post-
operative pain was assessed at rest using the visual 
analog scale (vAS) starting from 0 (no pain at all) to 
10 (worst pain imaginable). The intensity of postop-
erative pain was assessed by the investigator blinded 
to patient group allocation. Assessment was made at 
1, 3, 6, 9 and 24 hours postoperatively. According to 
vAS scale score, a bolus dose of intravenous analge-
sic was administered. metamizol 2.5 g was given for 
vAS scores 3-4, diclofenac 75 mg for vAS scores 5-7, 
and tramadol 1 mg/kg for vAS scores 8-10. during 
the postoperative period, any adverse events or side 
effects, especially nausea, vomiting, bradycardia and 
hypotension, were recorded. data were statistically 
analyzed and expressed as mean ± standard deviation 
(Sd). Parametric data were compared using analysis 
of variance (AnOvA) and postoperative analgesic 
data using χ2-test. mann whitney u test was used to 
evaluate differences between the groups in vAS scores 
according to postoperative hours, and fisher’s exact 
test to compare differences between the groups in the 
number of patients requiring analgesic at first postop-
erative hour and during 24 hours after surgery. P value 
<0.05 was considered statistically significant.
Results
groups were comparable with respect to age, 
weight, sex, preoperative pain level, duration of pneu-
moperitoneum and duration of operation (Table 1). 
no complications related to anesthesia, operative pro-
cedure or conversion were recorded.
There was no statistically significant difference 
in the incidence of postoperative nausea and vomit-
ing among the three groups. There were no cases of 
hemodynamic instability in the first 24 postoperative 
hours in all three groups of patients. The mean vAS 
scores for each group according to postoperative hour 
are shown in Table 2 and figure 1. At 1 hour postop-
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eratively, vAS scores at rest in group B were signifi-
cantly lower compared to group C (p<0.01) and group 
A (p<0.05). At 3 hours postoperatively, vAS scores 
in group B were also significantly lower compared to 
both group C and group A (p<0.05). There were no 
significant differences in vAS scores between groups 
C and A at 1 and 3 hours postoperatively. At 6, 9 and 
24 hours postoperatively, no statistically significant 
differences in vAS scores were recorded among the 
three groups.
in the first postoperative hour, all (100%) group 
C patients, 19 (95%) group A patients and 12 (60%) 
group B patients required analgesic. This difference 
was statistically significant (p<0.01 group B vs. group 
C and p<0.05 group B vs. group A ).
during the 24-hour period, all group C and group 
A patients required analgesic, while in group B there 
were 4 patients who did not require any analgesic, 
however, the difference was not statistically signifi-
cant. within the first 24 hours, metamizol consump-
tion was significantly lower in group B than in groups 







Age (yrs) 53.3±13.4 52.2±15.1 56.7±17.9
weight (kg) 73.4±13.6 76.6±11.2 75.2±12.3
Sex (m/f) 3/17 5/15 4/16
Preoperative pain level 1.7±1.5 1.6±1.6 1.7±1.5
duration of pneumoperitoneum (min) 28±12.4 29±13.6 26.7±8.8
Operation duration (min) 51.4±14.9 52.4±14.6 52.9±13.6
POnv 6/20 3/20 5/20
values are given as mean ± Sd; POnv = postoperative nausea and vomiting
Table 2. Mean visual analog scale scores for each group 
according to postoperative hour
Postoperative hour group A group B group C
1 4.7±1.7 3.2±1.8*† 5.2±2.0
3 3.7±1.8 2.4±1.5* 3.8±2.3
6 2.5±1.2 2.2±1.4 1.9±1.7
9 2.0±1.6 1.8±1.5 2.0±1.6
24 1.6±1.5 1.1±1.3 1.3±1.6
values given as mean ± Sd; *p<0.05 compared to group A; †p<0.01 
compared to group C 
C and A (p<0.001 vs. group C and p<0.05 vs. group 
A). diclofenac consumption was also lower in group 
B (p<0.05 vs. groups C and A).
Tramadol was administered to three patients in 
group C. no patient needed tramadol in groups A 
and B (fig. 2).
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Discussion
Although laparoscopic cholecystectomy is a pro-
cedure with many advantages over open cholecystec-
tomy, early postoperative pain still remains the main 
problem for some patients.
There is evidence that preoperative pain and in-
flammation cause worse postoperative pain level, 
probably through sensitization of the central nervous 
system.
in the first 24 hours, the site of most severe pain 
is the upper abdominal quadrant and port wounds2. 
in 30%-40% of patients, second peak of pain occurs 
after 24 hours and is referred to shoulder tip1. The na-
ture and mechanisms of pain after laparoscopic chole-
cystectomy are multifactorial because pain originates 
from three sources: port wounds, pneumoperitoneum 
(type of gas, pressure, temperature and volume of re-
sidual gas1) and cholecystectomy (visceral pain)1,10. 
in some studies, incisional pain predominated over 
visceral and shoulder tip pain3. Pneumoperitoneum 
causes neuropathic pain by chemical irritation, isch-
emia and compression1,11,12.
Pain is a subjective sensation, which makes mea-
surement of pain very difficult. multimodal analgesic 
approach is recommended for the treatment of post-
operative pain after laparoscopic cholecystectomy be-
cause of enhanced recovery and reduced risk of side 
effects13. According to consensus recommendations, 
paracetamol and nSAids are efficacious combination 
for postoperative analgesia following laparoscopic 
cholecystectomy and strong opioids should be avoided 
postoperatively13.
in this study, a weak opioid was used as a rescue 
analgesic for the worst pain levels, otherwise postop-
erative pain was treated with nSAids or metamizol. 
in our country, metamizol was one of the most used 
analgesics until parenteral paracetamol has become 
available.
nmdA receptor is an amino acid receptor in the 
brain and spinal cord responsible for excitatory syn-
aptic transmission14. nmdA antagonists may reduce 
pain and opioid consumption by two mechanisms: re-
duction in central hypersensitivity and wind-up-like 
states and by reducing opioid tolerance15. magnesium 
as a nmdA receptor antagonist can prevent the in-
duction of central sensitization after peripheral noci-
ceptive stimulation7. Analgesic efficacy of magnesium 
depends on the dose and regimen (bolus vs. continu-
ous infusion), surgical procedure (minor vs. major) 
and homeostasis16-19.
with intraoperative continuous iv. administra-
tion of magnesium sulfate, it is possible to raise serum 
magnesium levels and problems like prolonged action 
of nondepolarizing muscle relaxants, vasodilatation 
due to direct interaction with calcium ions at vascular 
membranes and cardiac conductivity disorders may 
occur14. This fact was used as a limitation in our study, 
so we used minimal dose (bolus dose of magnesium 
sulfate given for control of adrenergic response during 
intubation6) to detect if it can be effective in treating 
early postoperative pain. using this regimen, we had 
no major adverse effects of magnesium sulfate.
An increased pain relief was observed in patients 
who received 7.5 mg/kg magnesium sulfate iv. before 
surgical incision and it was evident in the first three 
postoperative hours. Pharmacological duration of a 
single intravenous injection of magnesium is signifi-
cantly shorter than of continuous administration and 
it could be the reason of a relatively short period of 
postoperative analgesic effect17,20. The most convinc-
ing result of magnesium efficacy in a dose of 7.5 mg/
kg in preventing postoperative pain was the lowest 
analgesic consumption when compared with magne-
sium sulfate dose of 5 mg/kg or saline.
in conclusion, preemptive intravenous admin-
istration of both 5.0 and 7.5 mg/kg of magnesium 
sulfate significantly reduced early postoperative pain 
after laparoscopic cholecystectomy, but 7.5 mg/kg was 
found to be more effective. no effect on pain reduc-
tion was recorded at 6, 9 and 24 hours after surgery 
and no adverse effects were noticed.
The results of our study suggest that magnesium 
has a significant specific antinociceptive effect through 
nmdA blockade. further prospective, randomized 
studies should investigate the role of magnesium as 
a useful adjuvant to postoperative analgesia after lap-
aroscopic surgery, especially differences in magnesium 
doses and regimens in postoperative pain control. 
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Sažetak
uČinAK niSKe dOZe PreemPTivnOg inTrAvenSKOg mAgneZiJ SulfATA nA rAnu 
POSliJeOPerACiJSKu BOl nAKOn lAPArOSKOPSKe KOleCiSTeKTOmiJe 
I. Bačak Kocman, R. Krobot, J. Premužić, I. Kocman, R. Stare, L. Katalinić i N. Bašić-Jukić
magnezij sulfat kao antagonist n-metil-d-aspartata ima analgetski učinak i smanjuje osjet boli tijekom operacijskog 
zahvata. Cilj ove studije bio je odrediti učinak preemptivne intravenske primjene male doze magnezij sulfata na bol u ra-
nom poslijeoperacijskom tijeku nakon laparoskopske kolecistektomije. u ovom prospektivnom randomiziranom istraživa-
nju 60 bolesnika ASA i-ii koji su podvrgnuti laparoskopskoj kolecistektomiji podijeljeno je u tri skupine po 20 bolesnika. 
nakon uvoda u anesteziju, a prije kirurškog reza, bolesnici su intravenski dobili 5 mg/kg magnezij sulfata (skupina A), 7.5 
mg magnezij sulfata (skupina B) ili fiziološku otopinu (skupina C). intenzitet poslijeoperacijske boli je ocijenjen vizualnom 
analognom skalom (vAS 0-10) 1, 3, 6, 9 i 24 sata nakon operacijskog zahvata. na osnovi zbroja vAS bolesnici bi intraven-
ski primili metamizol 2,5 mg (vAS 3-4), diklofenak 75 mg (vAS 5-7) ili tramadol 1 mg/kg (vAS 8-10). Zbrojevi vAS su 
prvog poslijeoperacijskog sata bili značajno niži u skupini A (4,7±1.7; P<0,05) i skupini B (3,2±1,8; P<0,01) nego u skupini 
C (5,2±2,0). Tri sata nakon operacijskog zahvata zbroj vAS u skupini B (2,4±1,5) je bio značajno niži nego u skupini A 
(3,7±1,8) ili skupini C (3,8±2,3) (P<0,05). nakon 6, 9 i 24 sata nije bilo razlike među skupinama. u zaključku, preemp-
tivna intravenska primjena 5,0 i 7,5 mg/kg magnezij sulfata značajno smanjuje poslijeoperacijsku bol nakon laparoskopske 
kolecistektomije, ali je 7,5 mg/kg bilo učinkovitije.
Ključne riječi: Magnezij sulfat; Kolecistektomija, laparoskopska; Bol, poslijeoperacijska
